Skip to Main Content

Paper Details

Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
Osteoporos Int
6
2020
PARTICIPANTS, RMMs, SR, cerebrovascular disease, ischaemic heart disease, osteoporosis, patient, patients, peripheral arterial disease, person, strontium ranelate, uncontrolled hypertension
Author NameAffiliation
Peter R RijnbeekErasmus University Medical Center
Peter R RijnbeekErasmus University Medical Center
Johan van der LeiErasmus University Medical Center
Johan van der LeiErasmus University Medical Center
Carlen ReyesIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Miriam C J M SturkenboomUniversity Medical Center
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Daniel Prieto-AlhambraBotnar Research Centre
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraIdiap Jordi Gol Primary Care Research Institute and CIBERFes, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III
Daniel Prieto-AlhambraBotnar Research Centre
  • 1 - 12

Datasets

Release 1.2